Daniel Stieber
YOU?
Author Swipe
View article: Unusual Causes of β Thalassemia Trait: Discovery of another Three Novel <i>SUPT5H</i> Variants
Unusual Causes of β Thalassemia Trait: Discovery of another Three Novel <i>SUPT5H</i> Variants Open
Beta (β) thalassemia is an inherited disorder that occurs following mutations or deletions in the β globin gene. Rarely, it is caused by variants in genes coding for erythroid transcriptional factors or trans-acting factors. Here, we repor…
View article: AUTS2-related syndrome: Insights from a large European cohort
AUTS2-related syndrome: Insights from a large European cohort Open
View article: Digital PCR cluster predictor: a universal R-package and shiny app for the automated analysis of multiplex digital PCR data
Digital PCR cluster predictor: a universal R-package and shiny app for the automated analysis of multiplex digital PCR data Open
Summary Digital polymerase chain reaction (dPCR) is an emerging technology that enables accurate and sensitive quantification of nucleic acids. Most available dPCR systems have two channel optics, with ad hoc software limited to the analys…
View article: Understanding the new <scp> <i>BRD4</i> </scp> ‐related syndrome: Clinical and genomic delineation with an international cohort study
Understanding the new <span> <i>BRD4</i> </span> ‐related syndrome: Clinical and genomic delineation with an international cohort study Open
BRD4 is part of a multiprotein complex involved in loading the cohesin complex onto DNA, a fundamental process required for cohesin‐mediated loop extrusion and formation of Topologically Associating Domains. Pathogenic variations in this c…
View article: TMOD-08. PRIMARY AND RECURRENT GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOX) REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION MEDICINE
TMOD-08. PRIMARY AND RECURRENT GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOX) REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION MEDICINE Open
Patient-derived cancer models are essential tools for studying tumor biology and for preclinical interventions. Although numerous clinical cancer trials are being conducted, many fail due to inappropriate selection of compounds at the prec…
View article: Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology Open
View article: GENE-02. ESTABLISHING PERSONALIZED TREATMENT OPTIONS FOR RECURRENT HIGH-GRADE GLIOMAS
GENE-02. ESTABLISHING PERSONALIZED TREATMENT OPTIONS FOR RECURRENT HIGH-GRADE GLIOMAS Open
BACKGROUND High grade glioma (HGG) patients develop resistance to standard treatment leading to disease progression and limited life expectancy. Recent advances in the molecular characterisation of treatment-naïve HGGs based on next genera…
View article: OS12.2 Targeting epigenetic pathways in the treatment of recurrent high-grade glioma
OS12.2 Targeting epigenetic pathways in the treatment of recurrent high-grade glioma Open
BACKGROUND High grade glioma (HGG) patients develop resistance to standard treatment leading to disease progression and limited life expectancy. Advances in the molecular characterisation of treatment-naïve HGGs based on next-generation se…
View article: Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens
Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens Open
Background Artificial genomic reference standards in a cytocentrifuge/cytospin format with well‐annotated genomic data are useful for validating next‐generation sequencing (NGS) on routine cytopreparations. Here, reference standards were o…
View article: Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment Open
View article: CADD-33. PERSONALIZED PHARMACOGENOMICS USING GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOXS)
CADD-33. PERSONALIZED PHARMACOGENOMICS USING GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOXS) Open
It is well recognized that long term cell cultures are poor models to study human cancer, largely because of loss of clonal heterogeneity, accumulation or loss of genomic alterations and adaptation to a highly artificial environment. Patie…
View article: TMOD-29. MOLECULAR CHARACTERIZATION OF GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS: FROM BASIC RESEARCH TO PRECLINICAL STUDIES
TMOD-29. MOLECULAR CHARACTERIZATION OF GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS: FROM BASIC RESEARCH TO PRECLINICAL STUDIES Open
It is well recognized that long term cell cultures are poor models to study human cancer, largely because of loss of clonal heterogeneity, accumulation or loss of genomic alterations and adaptation to a highly artificial environment. Patie…
View article: P04.64 Molecular characterization of glioma patient derived orthotopic xenografts to improve outcome of preclinical studies
P04.64 Molecular characterization of glioma patient derived orthotopic xenografts to improve outcome of preclinical studies Open
It is well recognized that long term cell cultures are poor models to study human cancer, largely because of loss of clonal heterogeneity, accumulation or loss of genomic alterations and adaptation to a highly artificial environment. Patie…
View article: PO-197 Patient-derived xenograft (PDX) models of glioblastoma: from basic research to preclinical studies
PO-197 Patient-derived xenograft (PDX) models of glioblastoma: from basic research to preclinical studies Open
Introduction Animal models are essential tools for basic research and preclinical therapeutic interventions. Although numerous clinical cancer trials are being conducted, many fail due to inappropriate selection of compounds at the precli…
View article: Stem Cell-Associated Heterogeneity in Glioblastoma Is a Result of Intrinsic Tumor Plasticity Shaped by the Microenvironment
Stem Cell-Associated Heterogeneity in Glioblastoma Is a Result of Intrinsic Tumor Plasticity Shaped by the Microenvironment Open
View article: Issue Information
Issue Information Open
This review of the literature on pediatric malignant thyroid lesions emphasizes the role of cytology in enabling the correct identification of specific malignant entities and their distribution in the diagnostic categories.The higher incid…
View article: Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer
Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer Open
Since the advent of monoclonal antibodies against epidermal growth factor receptor (EGFR) in colorectal cancer therapy, the determination of RAS mutational status is needed for therapeutic decision-making. Most prevalent in colorectal canc…
View article: P05.01 Patient-derived xenograft (PDX) model of glioblastoma: from basic research to preclinical studies
P05.01 Patient-derived xenograft (PDX) model of glioblastoma: from basic research to preclinical studies Open
Animal models are essential tools for basic research and for preclinical therapeutic interventions. Although numerous clinical trials have been conducted, most fail due to inappropriate selection of the compounds at the preclinical stage. …
View article: Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma Open
The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass an…